Moonlake Immunotherapeutics (MLTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Operating Expenses | 47,485 | 49,581 | 43,112 | 30,578 | 19,820 |
| Operating Income | -47,485 | -49,581 | -43,112 | -30,578 | -19,820 |
| Interest Expense | 18 | 0 | 0 | 0 | 0 |
| Other Income | 7,097 | 3,226 | 7,090 | 5,898 | 5,915 |
| Pre-tax Income | -40,406 | -46,355 | -36,022 | -24,680 | -13,905 |
| Income Tax | 153 | 41 | 92 | 79 | 70 |
| Net Income Continuous | -40,559 | -46,396 | -36,114 | -24,759 | -13,975 |
| Minority Interests | -615 | -790 | -724 | -492 | -302 |
| Net Income | $-39,944 | $-45,606 | $-35,390 | $-24,267 | $-13,673 |
| EPS Basic Total Ops | -0.63 | -0.72 | -0.56 | -0.39 | -0.22 |
| EPS Basic Continuous Ops | -0.64 | -0.74 | -0.57 | -0.39 | -0.22 |
| EPS Diluted Total Ops | -0.63 | -0.72 | -0.56 | -0.39 | -0.22 |
| EPS Diluted Continuous Ops | -0.64 | -0.74 | -0.57 | -0.39 | -0.22 |
| EPS Diluted Before Non-Recurring Items | -0.63 | -0.72 | -0.56 | -0.39 | N/A |
| EBITDA(a) | $-47,107 | $-49,217 | $-42,761 | $-30,236 | $-19,492 |